Healthcare & Life Sciences
Enobia
series-c-plus
series-c-plus
Stage
3
Investors
About
Enobia is a pharmaceutical company developing innovative therapeutics, likely at late-preclinical or clinical stages, as part of Rosetta Capital's life sciences portfolio.
Explore Enobia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.